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Abstract  
 
 
MDM2 is an important oncoprotein that downregulates the activity of the tumour suppressor 
protein p53 via binding of its N-terminal domain to the p53 transactivation domain. The first 24 
residues of the MDM2 N-terminal domain form an intrinsically disordered “lid” region that 
interconverts on millisecond time scale between “open” and “closed” states in unliganded 
MDM2. While the former conformational state is expected to facilitate p53 binding, the latter 
competes in a pseudo-substrate manner with p53 for its binding site. Phosphorylation of serine 
17 in the MDM2 lid region is thought to modulate the equilibrium between “open” and “closed” 
lid states, but contradictory findings on the favoured lid conformational state upon 
phosphorylation have been reported. Here the nature of the conformational states of MDM2 
pSer17 and Ser17Asp variants was addressed by means of enhanced sampling molecular 
dynamics simulations. Detailed analyses of the computed lid conformational ensembles indicate 
that both lid variants stabilise a “closed” state with respect to wild type. Nevertheless the nature 
of the closed state conformational ensembles differs significantly between the pSer17 and 
Ser17Asp variants. Thus care should be applied in the interpretation of biochemical experiments 
that use phospho-mimetic variants to model the effects of phosphorylation on the structure and 
dynamics of this disordered protein region.    
 
 
 
 
  
 4 
The tumor suppressor protein p53 is down-regulated by the ubiquitin ligase MDM2 in 
normal cells. This negative control occurs via recognition of the trans-activation domain (TAD) 
of p53 by the N-terminal region of MDM2 (ca.120 residues), which in turn initiates 
ubiquitination and degradation of p53.
1-4
 However, in response to stress conditions in the cell 
(e.g. DNA damage), phosphorylation of MDM2 and/or p53 can lead to p53 activation by 
disruption of p53/MDM2 complexes.
5-9
 In more than 50% of tumors, this regulatory mechanism 
is altered as a result of MDM2 overexpression, leading to inactivation of the tumor-supressive 
functions of p53 such as apoptosis or cell repair.
10,11
 
Despite important efforts to elucidate the role played by phosphorylations in p53 
reactivation by MDM2,
12
 detailed molecular mechanisms remain elusive. Attention has focussed 
especially on phosphorylation of MDM2 residue Ser17 that is located within a disordered, 
flexible “lid” (residues 1-24) region of the N-terminal domain of MDM2. The remainder of the 
domain, residues 25-120, is natively folded and referred as the MDM2 “core” region in this 
report. The MDM2 core region contains the p53 binding site within the “Phe19-Trp23-Leu26 
hydrophobic cleft” (Figure 1).  In unliganded MDM2 the lid region is in equilibrium between a 
“closed” state that competes with p53 for access to the p53 binding site via a pseudo-substrate 
mechanism, and an “open” state in which the lid is distant from the p53 binding site, enabling 
access to p53.
13
 Diverse approaches including biochemical, biophysical  and computer modelling 
have sought insights into the molecular mechanisms by which phosphorylation of Ser17 
modulates MDM2 interactions with p53.
13-17
 McCoy et al. performed NMR measurements on a 
Ser17Asp (S17D) phospho-mimetic MDM2 construct (16-125) to conclude that Ser17 
phosphorylation increased the affinity of the lid for the MDM2 hydrophobic pocket, and 
hindered formation of p53-MDM2 complex.
13
 By contrast, Worrall et al. showed via 
 5 
biochemical studies an increase of the ubiquitin ligase activity of full-length phospho-mimetic 
MDM2, which they attributed to an enhanced stability of MDM2-p53 complexes due to 
stabilisation of the phosphorylated lid in an open state.
14,16,17
  In disagreement with these results 
Zhan et al.,
15
 reported biochemical experiments suggesting that neither phosphorylation of Ser17 
nor Ser17Asp mutation have a significant effect on the binding of p53 TAD to MDM2.  
Molecular dynamics simulations studies have sought to establish how phosphorylated 
pSer17 or Ser17Asp modifications modulate the conformational preferences of the MDM2 lid.
18-
20
 Conventional protein MD simulations sample readily nano to micro second timescales of 
dynamics, which is insufficient for studies of the MDM2 lid dynamics since NMR experiments 
have shown that the MDM2 lid exchanges between “closed” and “open” conformations on a ca. 
10 ms time scale.
21
 To facilitate MD studies of disordered protein regions,
22
 our group has 
proposed and applied different computational methodologies to c-Myc,
23
 and MDM2.
24
 The 
methodology used for the preceding MDM2 study of apo and holo wild type lid dynamics 
combined accelerated molecular dynamics (aMD),
25-27
 umbrella sampling (US)
28
 and variational 
free energy profile (vFEP)
29,30
 techniques. Given the experimental uncertainties in the impact of 
MDM2 phosphorylation on lid interactions, this protocol was here applied to establish the 
conformational preferences of unliganded wild type, pSer17 and Ser17Asp MDM2 lid variants.   
 
Materials and Methods 
Detailed description of system setup and MD simulation protocols is fully described in 
previous work on holo MDM2 lid dynamics.
24
 For the sake of clarity the protocol is briefly 
described below and emphasis is given on methodological aspects specific to the present work. 
Systems setup 
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Three different models of the N-terminal domain of human MDM2 were prepared for 
molecular modelling studies: wild-type MDM2 (WT-MDM2), phosphorylated Ser17 MDM2 
(pSer17-MDM2), and the phospho-mimetic Asp17 variant (S17D-MDM2). All models were 
based on the NMR solution ensemble of the N-terminal domain of MDM2 (residues 1-119) 
(PDB ID:1Z1M).
31
 Models were prepared with the leap utility from the Amber12 suite,
32
 using 
the ff99SBildnmr forcefield.
33
 Forcefield parameters for phosphorylated Ser17 were taken from 
Homeyer et al.
34
 Each protein was immersed in a cubic periodic box of TIP3P water molecules
35
 
that extended 15Å away from any solute atom and neutralized by addition of appropriate number 
of Cl
-
 counter ions.
36
  
 
Molecular dynamics simulations protocols 
The MDM2 lid region interchanges between closed and open conformation on a multi ms time-
scale.
21
 As a result, conventional molecular dynamics (cMD) protocols are insufficient to 
efficiently sample the thermally accessible conformational space of the MDM2 lid region. This 
limitation was here overcome by combining accelerated molecular dynamics (aMD),
25-27
 
umbrella sampling (US)
28
 and variational free energy profile (vFEP) methodologies.
29,30
 
Preliminary cMD simulations were performed to determine the parameters needed to set up aMD 
simulations. Unlike methodologies such as metadynamics,
37,38
 aMD does not require a 
predefined collective variable to enhance the sampling. In aMD a biasing term, ΔV(r), is added 
when the the potential energy function, V(r), is below a predefined value (Ep). The resulting 
potential, V*(r), given by Eq1, contributes to reducing the height of energy barriers that 
separates different energy minima: 
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𝑉∗(𝒓) = {
𝑉(𝒓)
𝑉(𝒓) +  ∆𝑉(𝒓)
     𝑉(𝒓) > 𝐸𝑝
     𝑉(𝒓) < 𝐸𝑝
.                   (1) 
In this work, 100ns aMD simulations were run for each system, using a dual boost protocol: one 
boost was applied to the total potential energy and an extra boost was added to the dihedral 
torsions (using iamd=3 keyword in AMBER 12): 
∆𝑉(𝒓) =
(𝐸𝑃−𝑉(𝒓))
2
(𝛼𝑝+𝐸𝑝−𝑉(𝒓))
+
(𝐸𝐷−𝑉𝐷(𝒓))
2
(𝛼𝐷+𝐸𝐷−𝑉𝐷(𝒓))
,   (2) 
where VD is the dihedral energy, EP and ED are the reference potential and dihedral energies and 
αP and αD are the acceleration parameters that describe the strength of the boost for each term. 
The chosen aMD parameters were initially set according to guidelines from previous works, 
25,39
 
and subsequently modified until an enhancement in the sampling of lid conformations was 
achieved. The final parameters are shown in Table S1. To further focus the conformational 
sampling on the lid region, positional restraints were applied to the MDM2 core domain 
(residues 30 to 119) (20 kcal mol
-1 Å-2) whereas residues 1 to 29 were allowed to evolve freely. 
Those restrictions were subsequently removed prior to the beginning of the US calculations.  
 Although aMD simulations were helpful to provide an enhanced sampling of lid 
conformations for WT-MDM2, pS17-MDM2 and S17D-MDM2 variants, the technique does not 
provide reliable information about the relative populations of the sampled conformations (Figure 
S1). To obtain equilibrium data (populations) from the biased aMD simulations, an Umbrella 
sampling calculation (US) is thus subsequently performed. Two collective variables were 
identified which could discriminate between several lid states: CV1 defines the extension of the 
lid as a function of the distance between the alpha carbons of residues 1 and 23 while CV2 is 
defined by the angle between the alpha carbons of residues 11, 50 and 62 (lid-core angle) (Figure 
1). With these definitions the p53 binding site may be considered occluded by the MDM2 lid 
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when the lid-core angle is below 80º and the lid extension is larger than 24 Å. Other values 
would lead to an “open” state of the lid. US simulations were performed for WT,24 pS17 and 
S17D variants. CV1 was sampled from 3 Å to 49 Å with a 2 Å interval and CV2 from 20º to 
140º with a 6º interval. A total of 504 windows were thus defined. Each window used as a 
starting point the closest snapshot obtained during the preceding aMD simulations. aMD and US 
protocol example input files are provided in the SI (Dataset S1). A harmonic constraint of 1 kcal 
mol
-1
 Å
-2
 and 0.12 kcal mol
-1
 deg
-2
 was used for CV1 and CV2 respectively. For each simulation 
bin, 500 ps simulation were performed to pre-equilibrate the system before accumulating 
statistics for 4 ns. Free energy profiles were obtained using the 2D variational Free Energy 
Profile (vFEP) method.
29,30
 To estimate uncertainties in bin free energies, all US trajectories 
were sub-divided into four parts of equal duration and analysed separately (Fig. S2). 
 
Analysis of the molecular dynamics trajectories 
Trajectories and 3-D structures were visually inspected using Pymol
40
 and VMD.
41
 
RMSDs, hydrogen bonds and hydrophobic lid/core contacts were monitored using cpptraj 
module in AmberTools12.
42
 Average helical, sheet, turn or coil propensities were computed 
according to the DSSP code. 43,44 The formation of a hydrogen bond was considered when the 
distance between donor and acceptor was shorter or equal to 3.0 Å and the angle between the 
acceptor, hydrogen and donor atoms was equal or larger than 154°. A hydrophobic contact was 
defined when the distance between two carbon atoms was less than 5 Å. To avoid counting a 
large number of trivial contacts, for every lid residue i, intramolecular lid-lid hydrophobic 
contacts with immediate neighbouring residues (i+1, i-1) were excluded from the analysis. 
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All observables were obtained by reweighting statistics from the US snapshots according 
to equation 3. 
< 𝐴𝑖 > =  
∑ (
1
𝑀
∑ 𝐴𝑗,𝑘
𝑀
𝑘=1 )∙
𝑁
𝑗=1 𝑒
−𝛽Δ𝐺𝑗
∑ 𝑒
−𝛽Δ𝐺𝑗𝑁
𝐽=1
,        (3) 
where <Ai> is the ensemble average of the property of interest for the lid residue i, N is the 
number of US bins, M is the number of snapshots in bin j, Aj,k is the value of the property Ai for 
snapshot k in bin j and ΔGj is the free energy of bin j obtained by vFEP reweighting. To estimate 
uncertainties in the computed properties, the simulation data was split in four consecutive blocks 
of 1 ns each and property values computed separately. Mean <Ai> values are reported along with 
one standard error. For each system, representative lid structural ensembles were obtained by 
randomly selecting 10 snapshots from the pooled US snapshots according to their computed 
equilibrium probabilities. Representative snapshots are provided as PDB files in the SI (Dataset 
S2). 
 
MMGBSA energy decomposition analysis 
In addition to structural parameters derived from equation 1, estimates in the lid-core energetics 
were sought by means of MMGBSA analyses. Here the energetics of “binding” (ΔGbinding) of the  
of the lid region (residues 1-24) to the core region (residues 30-100) was estimated via equation 
4 as implemented in the software MMPBSA.py.
45
 
𝛥𝐺𝑏𝑖𝑛𝑑𝑖𝑛𝑔,𝑠𝑜𝑙𝑣𝑎𝑡𝑒𝑑 = 𝛥𝐺𝑐𝑜𝑟𝑒+𝑙𝑖𝑑,𝑠𝑜𝑙𝑣𝑎𝑡𝑒𝑑 − [𝛥𝐺𝑐𝑜𝑟𝑒,𝑠𝑜𝑙𝑣𝑎𝑡𝑒𝑑 + 𝛥𝐺𝑙𝑖𝑑,𝑠𝑜𝑙𝑣𝑎𝑡𝑒𝑑 ]. (4) 
The free energy change associated with each term on the right-hand side of equation 4 is given 
by equation 5: 
𝛥𝐺𝑠𝑜𝑙𝑣𝑎𝑡𝑒𝑑 = 𝐸𝑔𝑎𝑠 + 𝛥𝐺𝑠𝑜𝑙𝑣𝑎𝑡𝑖𝑜𝑛 .      (5) 
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where Egas is the lid-core intermolecular gas phase energy, calculated using the AMBER force 
field (eq. 6).  
𝐸𝑔𝑎𝑠 = 𝐸𝑒𝑙𝑒𝑐 + 𝐸𝑣𝑑𝑊 .     (6) 
Bonded terms and intramolecular non-bonded energetics that are normally present in equation 6 
were not included here as a ‘single-trajectory’ protocol was used and their contribution therefore 
cancel out.
46
 The solvation free energy (ΔGsolvation) is decomposed into polar and non-polar 
contributions (eq. 7).  
𝛥𝐺𝑠𝑜𝑙𝑣𝑎𝑡𝑖𝑜𝑛 = 𝛥𝐺𝑝𝑜𝑙𝑎𝑟 + 𝛥𝐺𝑛𝑜𝑛−𝑝𝑜𝑙𝑎𝑟 .     (7) 
 
where polar contributions (ΔGpolar) to the solvation free energy are calculated by solving the 
generalized Born (GB) equation.
47
 Non-polar terms were estimated from the nonpolar solvent 
accessible surface area (SASA). 
𝛥𝐺𝑛𝑜𝑛−𝑝𝑜𝑙𝑎𝑟 = γSASA,      (8) 
 
where the surface tension constant γ has a value of 0.005 kcal mol-1 Å-2. Other contributions to 
the binding energetics (such as solvent, or conformational entropies) are omitted in the present 
analysis. The calculated energies were then decomposed into per-lid residue contributions.
48,49
 
 
The impact of Ser17 modifications on the MDM2 lid-core interaction energetics was 
determined by calculating the sum of polar interactions and the contribution of polar terms to the 
solvation free energy (ΔGelec,GB,i) and the sum of hydrophobic interactions and the contribution of 
non-polar groups to the solvation free energy (ΔGvdW,SA,i) for each lid residue i, minus the same 
the same values computed for WT-MDM2: 
ΔΔGelec,GB,i = [ΔGelec,GB,i]
S17*-MDM2 
- [ΔGelec,GB,i]
WT-MDM2
,
  
(9) 
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ΔΔGvdW,SA,i = [ΔGvdW,SA,i]
S17*-MDM2 
- [ΔGvdW,SA,i]
WT-MDM2 
,  (10) 
where S17* refers to the modified Ser17 (pS17 or S17D). 
 
 
Results 
Influence of Ser17 phosphorylation and Ser17Asp mutation on the free energy landscape of 
the MDM2 lid 
The free energy surfaces (FES) representing the conformational space occupied by the lid 
in  pS17-MDM2 and S17D-MDM2 were compared to the FES previously obtained for the WT-
MDM2 (Figure 2A).
24
 WT-MDM2 displayed one “closed” conformation at CV1 = 31 Å, CV2 = 
62º which corresponds to the lowest free energy region. Two local minima were located at CV1 
= 10 Å, CV2 = 64º, and CV1= 7 Å, CV2 = 119º corresponding to a “semi-closed” and fully 
“open” states respectively.  
The free energy surfaces (FES) obtained from US simulations of pS17-MDM2 showed 
one major low-free energy basin at CV1 = 27 Å; CV2 = 32º corresponding to a “closed” state of 
the lid and two additional local minima (CV1 = 12 Å; CV2 = 50º and CV1 = 20 Å; CV2 = 90º) 
that correspond to “semi-open” conformations 1 and 2 respectively (Figure 2B). However, fully 
“open” states were not detected in low free energy regions, in contrast to what was observed for 
WT-MDM2 (Figure 2A) where a fully accessible p53-binding pocket was present at CV1=7 Å, 
CV2=119º. The “closed” state in pS17-MDM2 also displays a semi-extended lid adopting a 
lower CV2 angle compared to the one observed for the WT-MDM2, as a result of a tighter 
interaction of the lid with helix α2 (Figure 2B). In this conformation, binding of the p53 TAD is 
hindered as a result of steric clashes with the lid, but nevertheless, the Phe19-Trp23-Leu26 cleft 
appears still accessible to small molecules such as Nutlins. The “semi-open” conformations were 
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similar to those detected in WT-MDM2: the lid adopts a semi-extended conformation 
approaching the core of MDM2, partially occluding the hydrophobic pocket of MDM2. 
Although this conformation would still limit the binding of p53, smaller MDM2 binders can 
access the binding site. 
The FES of the phospho-mimetic S17D-MDM2 displayed a main free energy region at a 
“closed” conformation (CV1 = 29 Å; CV2= 56º) (Figure 2C). In this case, the lid-core angle is 
larger than the one observed for pS17 MDM2 and resembles more to the “closed” conformation 
of the WT-system. In this state, the hydrophobic cleft of MDM2 remains inaccessible to p53 
TAD but, as was the case for WT-MDM2 and pSer17-MDM2, binding of small molecules is 
unlikely to be hindered. A second low free energy region corresponding to a “semi-open” 
conformation was detected in S17D-MDM2, in which the semi-extended configuration leads to a 
partially accessible hydrophobic pocket of MDM2. Interestingly, the lid was shown to be more 
extended compared to several “semi-open” conformations detected for pS17-MDM2 or WT-
MDM2 (20 Å vs 10 Å). Finally, as for pS17-MDM2, no fully open conformations were detected 
for S17D-MDM2. 
 
Impact of pSer17 and Ser17Asp modifications on MDM2 lid-core interactions. 
 The computed lid-core interactions of pS17-MDM2 and in S17D-MDM2 were inspected 
to provide a rationale for the different configurations observed in the FES. pSer17 in pSer17-
MDM2 is frequently involved in hydrogen-bonding or electrostatic interactions (Figure 3A, left 
panel). Inspection of the conformational ensemble indicates that these arise predominantly in a 
‘closed’ lid conformation that involves charge-charge interactions of pSer17 with residues His96 
and Arg97. In addition, Tyr100 in helix α2', is frequently hydrogen-bonded to the pS17 
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backbone nitrogen (Figures 4A-B). In this closed lid conformation lid residue Ile19 is involved 
in significant non-polar (Figure 3A), and these contacts arise predominantly from packing with 
Tyr104. Finally, a backbone (NH)-backbone (CO) polar interaction is observed between Asn3 
and Ans5 at the N-terminal end of the lid (Fig 3A, right panel). 
The FES of pSer17-MDM2 contains a secondary low free energy region that was labelled 
“semi open state 1”. In this conformation the lid is more compact, with its N-terminal end 
approaching C-terminal lid region (Figure 4C). In this state, pS17 still interacts with His96, but 
Arg97 is involved in a salt-bride with Asp23 at the C-terminal end of the lid. Three internal 
hydrogen bonds involving exclusively lid residues played an important role in the formation of 
the semi-extended conformation (Figure 3A right panel and Figure 4C). The Gln18 sidechain 
directly interacts with the phosphate from pS17, while Asp11 and Asn5 were hydrogen-bonded 
with Thr16 and Ileu19 respectively. The latter two residues also stabilize this conformation by 
establishing hydrophobic contacts with Met50 (Figure 3A left panel and Figure 4C). 
The third low free energy region observed in the FES, “semi-open state 2”, displayed a 
compact state of the lid. In this case, pSer17 preferentially interacted with Arg97 (Figure 4D). 
Here, most of the stabilizing interactions were shown to be hydrophobic. Particularly relevant 
were those involving Met6, Ileu19 and Pro20 that interacted with α2 helix residues Leu54 and 
Met50, partially occluding the accessibility to the p53-binding site (Figure 3A left panel, Figure 
4D). In addition, stable lid-lid hydrophobic contacts are established between Val14 and Met6 
while Met1 is in closed contact to Ala13 and Thr16 (Figure 3A right panel and Figure 4D). 
Remarkably the patterns of lid-core interactions in S17D-MDM2 were significantly 
altered compared with pSer17-MDM2. In the closed state, the S17D residue remained largely 
solvent exposed and instead Asp11 forms salt-bridges with His96, and occasionally with Lys94 
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(Figure 3B, Left panel and Figure 5A-B). The interaction between Asp25 (first core residue 
following the lid) and Lys51 stabilises further the closed state. The lid adopts nevertheless a 
closed state owing to non-polar contacts formed by the N-terminal residues Met1, Cys2 and 
Met6 and the hydrophobic pocket residues Met62 and Val93.(Figure 3B and 5B). Val14 also 
favours this conformation by means of hydrophobic contacts with Met50, and Leu54 from helix 
α2. Visualisation of the conformational ensemble indicates that these lid residues frequently 
protrude deep into the p53 binding site (Figure 5B). Overall, lid-lid interactions were weaker 
compared with the pS17-MDM2 variant, with the exception of Met1-Met6 hydrophobic contacts 
(Figure 3B, right Panel). Finally, the semi-open conformation observed in S17D-MDM2 shows 
the lid interacting with α2 helix leaving the p53 binding pocket partially accessible. Such 
conformation mainly involves hydrophobic contacts between Met1/Pro9 and Phe55 (Figure 3B 
and 5C).  
 
 
Impact of Ser17 phosphorylation and Ser17Asp mutation on MDM2 lid flexibility 
 
Next the flexibility of the lid region was assessed via RMSD calculations. The overall lid 
flexibility in pS17-MDM2 and S17D-MDM2 (6.4±2.2 Å and 5.6±1.7 Å, respectively) was 
higher than what had been computed previously for WT-MDM2 (4.1±1.0 Å).
24
 In WT-MDM2 
significant hydrophobic contacts  of the lid with helix 2 (e.g Ile19 and Ile20) contribute to a 
decrease in lid flexibility. By contrast in pS17-MDM2 and S17D-MDM2 the lid prefers to shift 
away from above helix 2 to occupy the p53 pocket where more space is available to 
accommodate conformational fluctuations.  
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Per-lid residue RMSD decomposition was used to gain finer insights into lid flexibility. 
In pSer17-MDM2 the most disordered residues were located at the N-terminal section of the lid. 
By contrast the C-terminal end close to the interface with the MDM2 core region was 
significantly more stable (Figure 6A). This is consistent with the previous observations 
indicating that the most important lid-core interactions in pS17-MDM2 involve residues pSer17 
to Glu23. The least flexible residues are pSer17 and Ile19 due to their relatively higher number 
of polar and Van der Waals contacts with other core residues. 
By contrast S17D-MDM2 shows broadly similar flexibility across N-terminal and C-
terminal sections of the lid. This explains the overall decreased flexibility of the lid in this 
construct. The stabilisation of the N-terminal section can be traced to the network of non-polar 
contacts that Met6 forms in the p53 binding site. Residue Ser17Asp is as flexible as 
neighbouring residues since it is predominantly solvent-exposed.  
Finally, the secondary structure propensities for every lid residue were computed for 
pS17-MDM2 and S17D-MDM2 (Fig. S3). While the non-phosphorylated lid displayed notable 
turn propensities near residues 8–13, 15–16 and 23–24 (Fig. S3A),24 secondary structure 
elements were largely absent for the modified Ser systems.. The observed decreased propensity 
for adoption of secondary structure elements is in line with the increased flexibility displayed by 
the lid residues in pS17-MDM2 and S17D-MDM2. 
 
Impact of Ser17 phosphorylation and Ser17Asp mutation on MDM2 lid-core interaction 
energetics 
Next insights into lid-core energetics were sought. Overall estimates of relative free 
energies between open and close lid conformations were not computed owing to the difficulties 
of accurate evaluation of associated entropy changes.
22
 Nevertheless insights can be gained in the 
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nature of the stabilising lid-core interactions by computing changes in residue interaction 
energies in pS17-MDM2 and S17D-MDM2 relative to WT-MDM2 (Figure 7). As expected, 
pS17 forms more favourable electrostatic interactions with the core with respect to unmodified 
Ser 17 (ΔΔGelec,GB = -27.4 ± 2.1 kcal mol
-1
) (Figure 7A). Contributions of Glu23 in pSer17-
MDM2 and Asp11 in S17D-MDM2 were also more favourable compared with wild type MDM2 
(ΔΔGelec,GB = -5.6 ± 0.2  kcal mol
-1
 and -2.6 ± 0.9 kcal mol
-1
 respectively). On the other hand, 
non-polar terms contributions in pS17-MDM2 were moderately favoured or, most frequently, 
disfavoured (Figure 7B). 
In S17D-MDM2 the contribution of polar lid residues are insignificant (ΔΔGelec,GB for 
S17D = -0.4 ± 0.3 kcal mol
-1
) (Figure 7A). The contribution of van der Waals interactions had as 
well a moderate effect on stabilizing the lid. Interestingly, the disfavoured non-polar 
contributions in the phospho-mimetic system corresponded to the lid residues located at the C-
terminal end of the lid (notably Ile19 and Pro20: ΔΔGvdW,SA = 5.8 ± 0.6 kcal mol
-1
 and ΔΔGvdW,SA 
= 6.2 ± 0.2 kcal mol
-1
 respectively). On the contrary, van der Waals contributions were shown to 
be moderately favoured at the N-terminal end (Met6: ΔΔGvdW,SA = -3.6 ± 0.1 kcal mol
-1
) 
 
Discussion 
Ser17 phosphorylation and Ser17Asp mutations stabilize closed conformations of the 
MDM2 lid  
In comparison with WT-MDM2, the most remarkable difference observed in the free 
energy surfaces of pS17-MDM2 and S17D-MDM2 was the absence of low free energy fully 
"open" conformations. In both constructs “closed” and “semi-open” states are predominantly 
formed and they completely or partially occlude the p53-binding site (Figure 2).Thus the present 
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results support the work of McCoy et al.,
13
 that suggested the S17D-MDM2 lid variant interacts 
more strongly with the MDM2 core region. The present results do not support the hypothesis of 
Worral et al. that the S17D mutation shifts the equilibrium towards an “open” lid state.16,17 
However such lid behaviour was inferred by Worral et al. from measured enhancements in the 
E3 ubiquitin ligase activity of S17D-MDM2 for p53. While the present results do not support the 
hypothesis that the MDM2 lid opens up upon phosphorylation, it remains possible that induced 
fit effects enable p53 to bind with phosphorylated MDM2, and that pSer17 or Ser17Asp plays a 
role in facilitating ubiquitination of p53 via MDM2. Indeed Zhan et al. have recently reported 
evidence that p53 may still bind to MDM2 independently of whether Ser17 is phosphorylated or 
mutated to its phospho-mimetic Ser17Asp.
15
 Thus consideration of the impact of additional 
phosphorylation events on p53 TAD and/or MDM2 is desirable to clarify the role of these post-
translational modifications on p53/MDM2 regulation.  
 
The pSer17 and Ser17Asp lid structural ensembles differ significantly  
Comparison of Figure 2A and 2B shows that the lowest free energy regions of the 
conformational ensemble of pS17-MDM2 occur at lower value of the CV2 angle than for WT-
MDM2. This indicates that the lid region in pS17-MDM2 lies on average closer to the MDM2 
2 helix in the core region which implies a tighter interaction with the p53 binding site and helix 
α2. Contacts analyses and visualisation of the computed ensembles indicates that the phosphate 
group of pS17 is predominantly involved in salt-bridge interactions with His96 and Arg97 
(Figures 3 and 4). These interactions, absent in WT lid,
24
  stabilize further the lid in a closed 
state.  
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Comparison of Figure 2C and Figure 2A shows that Ser17Asp also destabilizes open lid 
states with respect to wild-type, but detailed structural analyses demonstrates that this occurs via 
a completely different pattern of lid-core interactions than with pSer17. The Ser17Asp residue 
remains largely solvent exposed, as was Ser17 in WT-MDM2. However, in WT-MDM2 open lid 
conformations bring Ser17 and Asp11 in close proximity. Bringing the negatively charged 
Asp17 in close proximity to the negatively charged Asp11 is energetically disfavoured in S17D-
MDM2, as suggested by higher free energy value in open states (CV1 ca. 10 Å, CV2 ca. 110 
degrees). In WT-MDM2 closed lid conformations Asp11 lies above the α2 helix, but in S17D-
MDM2 this residue shifts position and predominantly forms salt-bridges with His96 and Lys94. 
This appears to ‘drag’ the rest of the N-terminal lid region from above the 2-helix to inside the 
p53 binding site, thus explaining the larger number of hydrophobic contacts of residues Met1 
and Met6 with MDM2 core residues (Figure 3B). These findings are corroborated by the per-lid 
residue energy decomposition analysis that indicates phosphorylation of Ser17 introduces 
significantly favourable lid-core electrostatic interactions, whereas mutation of Ser17 into Asp17 
has a smaller effect on interaction energetics (Figure 7). 
The different patterns of observed lid-core interactions also result in significant variations 
in lid flexibility. Whereas the lid in pS17-MDM2 broadly decreases in flexibility from the N to C 
terminal sides, the lid in S17D-MDM2 exhibit similar flexibility across the N and C-terminal 
sides (Figure 6). With respect to wild type, enhanced interactions of pSer17 or Asp11 with Lys94 
and His96 cause a shift away from the 2-helix, and concomitant loss of hydrophobic contacts. 
The result is an overall increase in lid flexibility.  
Overall the picture that emerges is that both phosphorylation of Ser17 or mutation of 
Ser17 into Asp17 further stabilises closed lid states, but the conformational preferences and 
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flexibility of the closed lid states vary significantly. In order to mimic the structural and 
functional effects of protein phosphorylations, Ser/Thr mutations to Asp/Glu are frequently 
employed in biochemical experiments. However, in many cases the phospho-mimetic systems do 
not faithfully recapitulate the effect of protein phosphorylation,
50,51
 due to important 
physicochemical differences between Glu or Asp and phosphorylated residues.
52
 For instance, 
phosphorylated Ser/Thr display a tetrahedral topology and generally a -2 net charge, whereas 
Asp or Glu are planar and carry a net charge of -1. Moreover, the respective side chains are also 
dissimilar in size, the carbon atom having a smaller radius than phosphorus and the carboxylate 
group of the phospho-mimetic residues displaying two oxygen instead of three. Thus caution 
should be applied when interpreting the structural consequences of residue phosphorylation via 
phospho-mimetic analogues for this disordered protein region. 
CONCLUSIONS 
Molecular dynamics simulations support the hypothesis that phosphorylation of Ser17, or 
mutation of Ser17 into Asp17, both stabilise a closed conformational state of the MDM2 lid that 
is incompatible with binding of the p53 tumor suppressor. While both pS17-MDM2 and S17D-
MDM2 variants were shown to significantly influence MDM2 lid behaviour, they do so through 
distinct molecular recognition mechanisms. In pS17-MDM2 the closed lid state is stabilized by 
salt-bridges between pSer17 and Lys94/His96, whereas in S17D-MDM2 it is Asp11 that 
predominantly interacts with Lys94/His96. The present results provide a clear rationale for the 
effect of Ser17 mutations on MDM2 lid-core interactions in unliganded MDM2.  Further work is 
desirable to determine the consequences of phosphorylations on the stability of MDM2 bound to 
unphosphorylated and phosphorylated p53 peptide variants, and help formulate a fuller 
understanding of the role of post-translational modifications in p53 regulation.  
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Supporting Information 
The Supporting Information is available free of charge on the ACS Publications website at DOI: 
XX.XXXX. 
Dataset S1: Snapshots used to generate Figure 4 and Figure 5 (PDB format) 
Dataset S2: Sample input files for the aMD and US simulations. 
Table S1: aMD parameters used in the present simulations. All the parameters are given in 
kcal.mol
-1
. 
Figure S1: MDM2 lid distribution plot (in number of structures) projected on x: lid extension, in 
Å and y: lid-core angle, in degrees, obtained from aMD simulations. (A) WT-MDM2 
simulations, adapted from Bueren-Calabuig et al.,
24
 (B) pS17-MDM2, (C) S17D-MDM2. 
Figure S2: Free energy surfaces for the MDM2 lid conformational changes projected on CV1 (lid 
extension, in Å) and CV2 (lid-core angle, in degrees) in different time windows. Energies are in 
kcal.mol
-1
. (A) WT-MDM2 simulations, adapted from Bueren-Calabuig et al.,
24
 (B) pS17-
MDM2, (C) S17D-MDM2. 
Figure S3. MDM2 lid secondary structure propensity. Red: helix; Green: Turn; Yellow: β-
Strand. Black: Coil. Secondary structure definitions follow the DSSP code.
44
 (A) WT-MDM2 
simulations, adapted from Bueren-Calabuig et al.,
24
 (B) pS17-MDM2, (C) S17D-MDM2. 
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Figure Legends 
 
Figure 1. N-terminal domain of apo-MDM2 (residues 1–119) displaying the “open” and 
“closed” conformations. The lid (residues 1-24) is shown in green, the core (25-119) is displayed 
in blue. (A) The lid adopts an “open” conformation in the presence of the p53 transactivation 
domain (TAD) (in magenta). p53 residues Phe19, Trp23 and Leu26 protruding into the MDM2 
hydrophobic pocket are shown in sticks. (B) MDM2 lid “closed” conformation competing with 
p53 for its binding site in the MDM2 core. 
 
Figure 2. Free energy landscapes of wild type and modified Ser17-MDM2 lid. CV1 (lid 
extension) in Å and CV2 (lid-core angle) in degrees. Free energy contours (kcal mol
-1
) are shown 
as a colour coded heat map. For every system, representative structures of MDM2 displaying 10 
lid conformations from the global and local minima are shown. Ser17 is represented in red sticks. 
(A) WT-MDM2, adapted from Bueren-Calabuig et al.
24
 (B) pS17-MDM2 (C) S17D-MDM2  
 
Figure 3. MDM2 lid intermolecular and intramolecular interactions in pS17-MDM2 and S17D-
MDM2. Lid-core and lid-lid hydrophobic contacts are shown in red and maroon respectively; 
core and lid-lid hydrogen bonds are displayed in blue and green respectively. (A) pS17-MDM2 
(B) S17D-MDM2. Left) lid-core intermolecular interactions. Right) lid-lid intramolecular 
interactions. 
 
Figure 4. MDM2 lid structural ensemble for pS17-MDM2. Structural ensemble (A) and 
structural details of the closed (B) and semi open states 1 (C) and 2 (D). 
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Figure 5. MDM2 lid structural ensemble for S17D-MDM2. Structural ensemble (A) and 
structural details of the closed (B) and semi open states (C). 
 
Figure 6. MDM2 lid flexibility. Per residue average RMSD in pS17-MDM2 (A) and S17D-
MDM2 (B). 
 
Figure 7. Impact of Ser17 modification on lid-core binding energetics. (A) Decomposition of the 
contribution of the polar interaction energies to the total binding free energy for the pS17 MDM2 
(black) and S17D (grey): ΔΔGelec,GB=[ΔGelec,GB]
S17*-MDM2 
- [ΔGelec,GB]
WT-MDM2 
(B) Decomposition 
of the contribution of the non polar interaction energies to the total binding free energy for the 
pS17 MDM2 (black) and S17D (grey): ΔΔGvdW,SA=[ΔGvdW,SA]
S17*-MDM2 
- [ΔGvdW,SA]
WT-MDM2 
S17* represents pS17 or S17D.
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